首页> 外文期刊>Bioinformatics >EDGE COVID-19: a web platform to generate submission-ready genomes from SARS-CoV-2 sequencing efforts
【24h】

EDGE COVID-19: a web platform to generate submission-ready genomes from SARS-CoV-2 sequencing efforts

机译:EDGE COVID-19:一个网络平台,用于从 SARS-CoV-2 测序工作中生成可提交的基因组

获取原文
获取原文并翻译 | 示例

摘要

Genomics has become an essential technology for surveilling emerging infectious disease outbreaks. A range of technologies and strategies for pathogen genome enrichment and sequencing are being used by laboratories worldwide, together with different and sometimes ad hoc, analytical procedures for generating genome sequences. A fully integrated analytical process for raw sequence to consensus genome determination, suited to outbreaks such as the ongoing COVID-19 pandemic, is critical to provide a solid genomic basis for epidemiological analyses and well-informed decision making. We have developed a web-based platform and integrated bioinformatic workflows that help to provide consistent high-quality analysis of SARS-CoV-2 sequencing data generated with either the Illumina or Oxford Nanopore Technologies (ONT). Using an intuitive web-based interface, this workflow automates data quality control, SARS-CoV-2 reference-based genome variant and consensus calling, lineage determination and provides the ability to submit the consensus sequence and necessary metadata to GenBank, GISAID and INSDC raw data repositories. We tested workflow usability using real world data and validated the accuracy of variant and lineage analysis using several test datasets, and further performed detailed comparisons with results from the COVID-19 Galaxy Project workflow. Our analyses indicate that EC-19 workflows generate high-quality SARS-CoV-2 genomes. Finally, we share a perspective on patterns and impact observed with Illumina versus ONT technologies on workflow congruence and differences.
机译:基因组学已成为监测新发传染病暴发的重要技术。全世界的实验室正在使用一系列用于病原体基因组富集和测序的技术和策略,以及用于生成基因组序列的不同(有时是临时的)分析程序。从原始序列到共识基因组测定的完全集成分析过程,适用于正在进行的 COVID-19 大流行等疫情,对于为流行病学分析和知情决策提供坚实的基因组基础至关重要。我们开发了一个基于网络的平台和集成的生物信息学工作流程,有助于对使用Illumina或Oxford Nanopore Technologies(ONT)生成的SARS-CoV-2测序数据进行一致的高质量分析。该工作流程使用基于 Web 的直观界面,可自动执行数据质量控制、基于 SARS-CoV-2 参考的基因组变异和共识调用、谱系确定,并提供将共识序列和必要元数据提交到 GenBank、GISAID 和 INSDC 原始数据存储库的能力。我们使用真实世界的数据测试了工作流程的可用性,并使用多个测试数据集验证了变异和谱系分析的准确性,并进一步与COVID-19 Galaxy项目工作流程的结果进行了详细比较。我们的分析表明,EC-19 工作流程可生成高质量的 SARS-CoV-2 基因组。最后,我们分享了Illumina与ONT技术在工作流程一致性和差异方面观察到的模式和影响。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号